BJDX
Bluejay Diagnostics, Inc.Company Information
- Company Name
- Bluejay Diagnostics, Inc.
- CIK
- CIK0001704287
- Category
- <br>Emerging growth company
- Ticker: Exchange
- BJDX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- BJDX
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-07-09
- Last sale
- 2026-07-10
- Shares purchased (TTM)
- 126,547
- Shares sold (TTM)
- 34,938
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 216,120
- Shares outstanding
- 2,079,263
- Ownership
- 10.39%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -20.76%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 10 | 4 | 5 | 3 | 4 | 3 | 4 | 6 | 8 | 3 | 2 | 5 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Deferred Offering Costs | - | - | - | 0 | - | - | - | - | - | - | 0 | - | ||||||
| Assets Held For Sale Not Part Of Disposal Group Current | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Assets Current | 10 | 4 | 5 | 3 | 5 | 4 | 5 | 7 | 9 | 3 | 3 | 7 | ||||||
| Property Plant And Equipment Net | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 12 | 6 | 7 | 5 | 6 | 5 | 7 | 8 | 11 | 5 | 5 | 8 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Notes Payable Current | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Liabilities Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | ||||||
| Operating Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 55 | 48 | 47 | 44 | 44 | 40 | 40 | 40 | 40 | 33 | 30 | 30 | ||||||
| Retained Earnings Accumulated Deficit | -46 | -43 | -42 | -40 | -38 | -37 | -35 | -33 | -32 | -29 | -27 | -25 | ||||||
| Stockholders Equity | 9 | 4 | 6 | 4 | 5 | 4 | 6 | 7 | 9 | 3 | 3 | 5 | ||||||
| Liabilities And Stockholders Equity | 12 | 6 | 7 | 5 | 6 | 5 | 7 | 8 | 11 | 5 | 5 | 8 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 8 | 8 | 250 | 8 | ||||||
| Common Stock Shares Issued | 2 | 1 | 1 | 2 | 1 | 1 | 0 | 18 | 3 | 3 | 3 | 1 | ||||||
| Shares Outstanding | 2 | 1 | 1 | 2 | 1 | 1 | 0 | 18 | 3 | 3 | 3 | 1 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBluejay Diagnostics, Inc. (BJDX) — SEC Financial Statements & Analysis
Bluejay Diagnostics, Inc. (BJDX) is a surgical & medical instruments & apparatus company, incorporated in DE. Bluejay Diagnostics, Inc. trades on Nasdaq as: BJDX. Bluejay Diagnostics, Inc. (BJDX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Bluejay Diagnostics, Inc. carries a market cap of $2.50M, a P/E ratio of -0.34x, a P/B ratio of 0.27x, a P/S ratio of -3835.41x, an enterprise value of $-7.10M, and an EV/EBITDA multiple of 0.98x. On profitability, it posts an operating margin of 4167.24%, a net margin of 4030.44%, a Return on Equity (ROE) of -98.89%, a Return on Assets (ROA) of -81.07%, and a Return on Invested Capital (ROIC) of -1123.15%. Per share, it reports EPS of $-3.50, diluted EPS of $-3.50, free cash flow per share of $-2.92, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -63.57% year-over-year, and EPS growth of -93.92% year-over-year. On the balance sheet, it maintains a current ratio of 4.64x, a quick ratio of 4.54x, working capital of $7.70M, a debt-to-equity ratio of 0.23x, a debt ratio of 0.18, an interest coverage ratio of -11939.46x, free cash flow of $-6.06M (TTM), and net debt of $-9.60M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.50M
- P/E TTM
- -0.34x
- EPS TTM
- $-3.50
- P/B TTM
- 0.27x
- ROE TTM
- -98.89%
- ROA TTM
- -81.07%
- Debt To Equity
- 0.23x
- Free Cash Flow TTM
- $-6.06M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Bluejay Diagnostics, Inc. in?
Bluejay Diagnostics, Inc. (BJDX) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does BJDX trade on?
Bluejay Diagnostics, Inc. (BJDX) trades on the Nasdaq.
Where is Bluejay Diagnostics, Inc. incorporated?
Bluejay Diagnostics, Inc. is incorporated in DE.
When was Bluejay Diagnostics, Inc. (BJDX)'s most recent SEC filing?
Bluejay Diagnostics, Inc. (BJDX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is BJDX's market cap?
Bluejay Diagnostics, Inc. (BJDX) has a market capitalization of $2.50M as of 2026-06-30.
What is BJDX's EPS (earnings per share)?
Bluejay Diagnostics, Inc. (BJDX)'s trailing twelve month EPS is $-3.50 as of 2026-06-30.
What is BJDX's ROE (return on equity)?
Bluejay Diagnostics, Inc. (BJDX)'s trailing twelve month Return on Equity (ROE) is -98.89% as of 2026-06-30.
What is BJDX's ROA (return on assets)?
Bluejay Diagnostics, Inc. (BJDX)'s trailing twelve month Return on Assets (ROA) is -81.07% as of 2026-06-30.
What is BJDX's ROIC (return on invested capital)?
Bluejay Diagnostics, Inc. (BJDX)'s trailing twelve month Return on Invested Capital (ROIC) is -1123.15% as of 2026-03-31.
What is BJDX's EV/EBITDA?
Bluejay Diagnostics, Inc. (BJDX)'s trailing twelve month EV/EBITDA is 0.98x as of 2026-06-30.